All Videos Channels
  3. The Great 2024 Recession Is Over | $OXY Fundamental Analysis

    The Great 2024 Recession Is Over | $OXY Fundamental Analysis

    15
    1
    199
    3
  4. Is Microsoft Stock Overvalued?! | MSFT Stock Analysis | Tech Stocks to buy

    Is Microsoft Stock Overvalued?! | MSFT Stock Analysis | Tech Stocks to buy

    12
    1
    1
  5. How to Select Multibagger Stocks _ How to do Fundamental Analysis on Stocks _ St

    How to Select Multibagger Stocks _ How to do Fundamental Analysis on Stocks _ St

    21
  6. The Calm Before The Storm | $RUM Fundamental Analysis

    The Calm Before The Storm | $RUM Fundamental Analysis

    12
    0
    185
    1
  12. 🚀 Luminar (LAZR) Comprehensive Technical Analysis Study: Setting Up for Bullish Momentum - 4/26/2024

    🚀 Luminar (LAZR) Comprehensive Technical Analysis Study: Setting Up for Bullish Momentum - 4/26/2024

    18
    1
  14. UNEXPECTED SURPRISE! Does AMC & GME Stock Have Something In Store For The Apes!?

    UNEXPECTED SURPRISE! Does AMC & GME Stock Have Something In Store For The Apes!?

    50
    1
  17. TORM High Risk and High Reward Fundamental Analysis! | $TRMD

    TORM High Risk and High Reward Fundamental Analysis! | $TRMD

    5
    0
    61
    2
  18. Forex part 8 - How to use Fundamental analysis | Earn on News | crashing bulls

    Forex part 8 - How to use Fundamental analysis | Earn on News | crashing bulls

    18
  19. CF Industries Stock Analysis: 1# Nitrogen Fertilizer Producer ($CF)

    CF Industries Stock Analysis: 1# Nitrogen Fertilizer Producer ($CF)

    2
    1
  20. Global Stock Buybacks ETF | Horizontal Support | ($IPKW)

    Global Stock Buybacks ETF | Horizontal Support | ($IPKW)

    37
    8
    2
    1
  21. Low-beta Stock Portfolio ETF | Weak Seasonality & Red-hot Indicators | ($SPLV)

    Low-beta Stock Portfolio ETF | Weak Seasonality & Red-hot Indicators | ($SPLV)

    128
    54
    94
    1
  22. Alector Stock Analysis: Is This Alzheimer's Drug Company a Strong Buy?

    Alector Stock Analysis: Is This Alzheimer's Drug Company a Strong Buy?

    8
    0
    1
    1